159 related articles for article (PubMed ID: 9791580)
1. [Diffuse leiomyomatosis with genital involvement and Alport syndrome. Report of two cases].
Le Bras A; David A; Knipping M; Mensier A; Heidet L; Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):523-8. PubMed ID: 9791580
[TBL] [Abstract][Full Text] [Related]
2. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
[TBL] [Abstract][Full Text] [Related]
3. [Diffuse esophageal leiomyomatosis. Apropos of 5 cases with 2 familial cases].
Leborgne J; Le Neel JC; Heloury Y; Audoin AF; David A; Babut JM; Lenne Y
Chirurgie; 1989; 115(4-5):277-85; discussion 286. PubMed ID: 2612274
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
[TBL] [Abstract][Full Text] [Related]
5. Diffuse leiomyomatosis associated with X-linked Alport syndrome: extracellular matrix study using immunohistochemistry and in situ hybridization.
Heidet L; Cai Y; Sado Y; Ninomiya Y; Thorner P; Guicharnaud L; Boye E; Chauvet V; Solal LC; Beziau A; Torres RG; Antignac C; Gubler MC
Lab Invest; 1997 Feb; 76(2):233-43. PubMed ID: 9042160
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
[TBL] [Abstract][Full Text] [Related]
7. Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes.
Oohashi T; Naito I; Ueki Y; Yamatsuji T; Permpoon R; Tanaka N; Naomoto Y; Ninomiya Y
Matrix Biol; 2011 Jan; 30(1):3-8. PubMed ID: 20951201
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary outcome of Alport syndrome with familial diffuse esophageal leiomyomatosis.
Livnat G; Best LA; Guralnik L; Bentur L
Pediatr Pulmonol; 2011 Jun; 46(6):614-6. PubMed ID: 21284097
[TBL] [Abstract][Full Text] [Related]
9. Structure of the human type IV collagen COL4A6 gene, which is mutated in Alport syndrome-associated leiomyomatosis.
Zhang X; Zhou J; Reeders ST; Tryggvason K
Genomics; 1996 May; 33(3):473-9. PubMed ID: 8661006
[TBL] [Abstract][Full Text] [Related]
10. [A case report of Alport syndrome with esophageal leiomyomatosis].
Chen Y; Li SL; Xiao HJ; Ding J
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):611. PubMed ID: 18082056
[No Abstract] [Full Text] [Related]
11. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.
Ueki Y; Naito I; Oohashi T; Sugimoto M; Seki T; Yoshioka H; Sado Y; Sato H; Sawai T; Sasaki F; Matsuoka M; Fukuda S; Ninomiya Y
Am J Hum Genet; 1998 Feb; 62(2):253-61. PubMed ID: 9463311
[TBL] [Abstract][Full Text] [Related]
12. [Esophageal leiomyomatosis revealing an Alport syndrome].
Abbes K; Ayadi L; Makni S; Kharrat M; Affes N; Kallel R; Gouiaa N; Ben Hmida M; Hachicha J; Beyrouti MI; Sellami Boudawara T
Rev Med Interne; 2009 Jan; 30(1):88-90. PubMed ID: 18433941
[TBL] [Abstract][Full Text] [Related]
13. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
14. Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.
Nozu K; Minamikawa S; Yamada S; Oka M; Yanagita M; Morisada N; Fujinaga S; Nagano C; Gotoh Y; Takahashi E; Morishita T; Yamamura T; Ninchoji T; Kaito H; Morioka I; Nakanishi K; Vorechovsky I; Iijima K
J Hum Genet; 2017 Jul; 62(7):733-735. PubMed ID: 28275241
[TBL] [Abstract][Full Text] [Related]
15. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours.
Heidet L; Dahan K; Zhou J; Xu Z; Cochat P; Gould JD; Leppig KA; Proesmans W; Guyot C; Guillot M
Hum Mol Genet; 1995 Jan; 4(1):99-108. PubMed ID: 7711741
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of basement membranes: the paradigm of Alport syndrome.
Antignac C
Kidney Int Suppl; 1995 Jun; 49():S29-33. PubMed ID: 7674589
[No Abstract] [Full Text] [Related]
17. Alport syndrome with diffuse leiomyomatosis.
Anker MC; Arnemann J; Neumann K; Ahrens P; Schmidt H; König R
Am J Med Genet A; 2003 Jun; 119A(3):381-5. PubMed ID: 12784310
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females.
Dahan K; Heidet L; Zhou J; Mettler G; Leppig KA; Proesmans W; David A; Roussel B; Mongeau JG; Gould JM
Kidney Int; 1995 Dec; 48(6):1900-6. PubMed ID: 8587250
[TBL] [Abstract][Full Text] [Related]
19. A Japanese family with Alport syndrome associated with esophageal leiomyomatosis: genetic analysis of COL4A5 to COL4A6 and immunostaining for type IV collagen subtypes.
Sugimoto K; Yanagida H; Yagi K; Kuwajima H; Okada M; Takemura T
Clin Nephrol; 2005 Aug; 64(2):144-50. PubMed ID: 16114791
[TBL] [Abstract][Full Text] [Related]
20. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.
Heidet L; Cohen-Solal L; Boye E; Thorner P; Kemper MJ; David A; Larget Piet L; Zhou J; Flinter F; Zhang X; Gubler MC; Antignac C
Cytogenet Cell Genet; 1997; 78(3-4):240-6. PubMed ID: 9465897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
